Recently, sotorasib, formerly AMG 510, a small molecule was approved for 3rd line of treatment in patients with KRAS G12C-mutated NSCLC after previous immunotherapy and/or chemotherapy [36]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.